(Q37207245)

18 August 2017

1 reference

title

Role of cannabinoids in the management of neuropathic pain (English)

1 reference

18 August 2017

0 references

0 references

0 references

M Isabel Martín Fontelles

series ordinal

1

1 reference

PubMed ID

18601303

18 August 2017

Carlos Goicoechea García

series ordinal

2

1 reference

18 August 2017

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

22

1 reference

18 August 2017

8

1 reference

18 August 2017

645-653

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200822080-00003

18 August 2017

0 references

cites work

Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200822080-00003

Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200822080-00003

CB2 cannabinoid receptor-mediated peripheral antinociception

21 January 2018

1 reference

12 December 2020

Recent developments in the therapeutic potential of cannabinoids.

1 reference

12 December 2020

Cannabinoid receptor localization in brain

1 reference

12 December 2020

A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats

1 reference

12 December 2020

1 reference

12 December 2020

Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.

1 reference

12 December 2020

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

1 reference

12 December 2020

The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors

1 reference

12 December 2020

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

1 reference

12 December 2020

Cannabinoid receptors and pain

1 reference

12 December 2020

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

12 December 2020

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

1 reference

12 December 2020

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

1 reference

12 December 2020

The biosynthesis, fate and pharmacological properties of endocannabinoids.

1 reference

12 December 2020

Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats

1 reference

12 December 2020

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

1 reference

12 December 2020

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models.

1 reference

12 December 2020

Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial

1 reference

12 December 2020

A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

1 reference

12 December 2020

Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide].

1 reference

12 December 2020

3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects

1 reference

12 December 2020

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

12 December 2020

Determination and characterization of a cannabinoid receptor in rat brain

1 reference

12 December 2020

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

1 reference

12 December 2020

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

1 reference

12 December 2020

Cannabinoid receptors and their ligands

1 reference

12 December 2020

Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision

1 reference

12 December 2020

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

1 reference

12 December 2020

Cannabinoid CB(1) receptor upregulation in a rat model of chronic neuropathic pain.

1 reference

12 December 2020

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

1 reference

12 December 2020

Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain

1 reference

12 December 2020

Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals.

1 reference

12 December 2020

Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat.

1 reference

12 December 2020

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

12 December 2020

CB1 receptor mediated analgesia from the Nucleus Reticularis Gigantocellularis pars alpha is activated in an animal model of neuropathic pain

1 reference

12 December 2020

Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors

1 reference

12 December 2020

Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain.

1 reference

12 December 2020

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

1 reference

12 December 2020

Effects of cannabidiol (CBD) on regional cerebral blood flow

1 reference

12 December 2020

1 reference

12 December 2020

[Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial]

1 reference

12 December 2020

Pain measurements and side effect profile of the novel cannabinoid ajulemic acid

1 reference

12 December 2020

Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats

1 reference

12 December 2020

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

12 December 2020

The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

1 reference

12 December 2020

Spinal cannabinoids are anti-allodynic in rats with persistent inflammation.

1 reference

12 December 2020

Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials

1 reference

12 December 2020

Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.

1 reference

12 December 2020

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist

1 reference

12 December 2020

Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons

1 reference

12 December 2020

A new human experimental pain model: the heat/capsaicin sensitization model

1 reference

12 December 2020

Cellular accumulation of anandamide: consensus and controversy

1 reference

12 December 2020

1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.

1 reference

12 December 2020

Prototype cannabinoid analgetics, prostaglandins and opiates — A search for points of mechanistic interaction

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

1 reference

12 December 2020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

12 December 2020

Control of pain initiation by endogenous cannabinoids.

1 reference

12 December 2020

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain

1 reference

12 December 2020

Cannabinoids and Neuropathic Pain

1 reference

12 December 2020

Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse

1 reference

12 December 2020

Cannabinoid CB1 Receptor Expression in Rat Spinal Cord

1 reference

12 December 2020

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial

1 reference

12 December 2020

Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation

1 reference

12 December 2020

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

1 reference

12 December 2020

Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment

1 reference

12 December 2020

Cannabinoid pharmacology: the first 66 years

1 reference

12 December 2020

Cannabimimetic properties of ajulemic acid

1 reference

12 December 2020

Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial

1 reference

12 December 2020

Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury.

1 reference

12 December 2020

10.2165/00023210-200822080-00003

Identifiers

DOI

1 reference

PubMed ID

18601303

Dimensions Publication ID

18 August 2017

0 references

1 reference

PubMed ID

18601303